Atrial fibrillation burden and atrial fibrillation type: Clinical significance and impact on the risk of stroke and decision making for long-term anticoagulation.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Vascular pharmacology

• Publication date

  2016-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.vph.2016.03.006PMID 27196706
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Rationale and design of the Apixaban for the Reduction of Thrombo‐Embolism in Patients With Device‐Detected Sub‐Clinical Atrial Fibrillation (ARTESiA) trial

  2017cited by this paper
• Lipoproteins as modulators of atherothrombosis: From endothelial function to primary and secondary coagulation.

  2016cited by this paper
• A roadmap to improve the quality of atrial fibrillation management: proceedings from the fifth Atrial Fibrillation Network/European Heart Rhythm Association consensus conference.

  2016cited by this paper
• 'Real-world' management and outcomes of patients with paroxysmal vs. non-paroxysmal atrial fibrillation in Europe: the EURObservational Research Programme-Atrial Fibrillation (EORP-AF) General Pilot Registry.

  2016cited by this paper
• The epidemiologic threat of atrial fibrillation: need for secondary, primary, and primordial prevention.

  2015cited by this paper
• Asymptomatic atrial fibrillation: clinical correlates, management, and outcomes in the EORP-AF Pilot General Registry.

  2015cited by this paper
• Predictors of silent brain infarction on magnetic resonance imaging in patients with nonvalvular atrial fibrillation: A transesophageal echocardiographic study.

  2015cited by this paper
• Management of atrial fibrillation in bradyarrhythmias

  2015cited by this paper
• Randomized trial of atrial arrhythmia monitoring to guide anticoagulation in patients with implanted defibrillator and cardiac resynchronization devices.

  2015cited by this paper
• Incidence of Stroke or Systemic Embolism in Paroxysmal Versus Sustained Atrial Fibrillation: The Fushimi Atrial Fibrillation Registry

  2015cited by this paper
• Risk of ischaemic stroke according to pattern of atrial fibrillation: analysis of 6563 aspirin-treated patients in ACTIVE-A and AVERROES.

  2015cited by this paper
• Device-detected atrial fibrillation: what to do with asymptomatic patients?

  2015cited by this paper
• Silent ischaemic brain lesions related to atrial high rate episodes in patients with cardiac implantable electronic devices.

  2015cited by this paper
• Improved outcomes with European Society of Cardiology guideline-adherent antithrombotic treatment in high-risk patients with atrial fibrillation: a report from the EORP-AF General Pilot Registry.

  2015cited by this paper
• Prognosis and treatment of atrial fibrillation patients by European cardiologists: one year follow-up of the EURObservational Research Programme-Atrial Fibrillation General Registry Pilot Phase (EORP-AF Pilot registry).

  2014cited by this paper
• Higher risk of death and stroke in patients with persistent vs. paroxysmal atrial fibrillation: results from the ROCKET-AF Trial

  2014cited by this paper
• Temporal Relationship Between Subclinical Atrial Fibrillation and Embolic Events

  2014cited by this paper
• Epidemiology of atrial fibrillation: European perspective

  2014cited by this paper
• AF burden is important – fact or fiction?

  2014cited by this paper
• Vascular effects of the Mediterranean diet-part II: role of omega-3 fatty acids and olive oil polyphenols.

  2014cited by this paper
• Newly detected atrial high rate episodes predict long-term mortality outcomes in patients with permanent pacemakers.

  2014cited by this paper
• 'Real-world' antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey.

  2014cited by this paper
• Clinical classifications of atrial fibrillation poorly reflect its temporal persistence: insights from 1,195 patients continuously monitored with implantable devices.

  2014cited by this paper
• Asymptomatic lone atrial fibrillation - how can we detect the arrhythmia?

  2014cited by this paper
• Vascular effects of the Mediterranean diet part I: anti-hypertensive and anti-thrombotic effects.

  2014cited by this paper
• Personalized management of atrial fibrillation: Proceedings from the fourth Atrial Fibrillation competence NETwork/European Heart Rhythm Association consensus conference.

  2013cited by this paper
• Health technology assessment in interventional electrophysiology and device therapy: a position paper of the European Heart Rhythm Association.

  2013cited by this paper
• Silent atrial fibrillation as a stroke risk factor and anticoagulation indication.

  2013cited by this paper
• Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060.

  2013cited by this paper
• Pattern of atrial fibrillation and risk of outcomes: the Loire Valley Atrial Fibrillation Project.

  2013cited by this paper
• Device-detected atrial fibrillation and risk for stroke: an analysis of >10 000 patients from the SOS AF project (Stroke preventiOn Strategies based on Atrial Fibrillation information from implanted devices)

  2013cited by this paper
• DEVICE DETECTED ATRIAL FIBRILLATION AND RISK FOR STROKE: AN ANALYSIS OF MORE THAN 10,000 PATIENTS FROM THE SOS AF PROJECT (STROKE PREVENTION STRATEGIES BASED ON ATRIAL FIBRILLATION INFORMATION FROM IMPLANTED DEVICES)

  2013cited by this paper
• The MOnitoring Resynchronization dEvices and CARdiac patiEnts (MORE-CARE) Randomized Controlled Trial: Phase 1 Results on Dynamics of Early Intervention With Remote Monitoring

  2013cited by this paper
• Outcomes of apixaban vs. warfarin by type and duration of atrial fibrillation: results from the ARISTOTLE trial.

  2013cited by this paper
• Atrial fibrillation, arrhythmia burden and thrombogenesis.

  2012cited by this paper
• Subclinical atrial fibrillation and the risk of stroke.

  2012cited by this paper
• Rate Control in Atrial Fibrillation

  2012cited by this paper
• Improving Thromboprophylaxis Using Atrial Fibrillation Diagnostic Capabilities in Implantable Cardioverter-Defibrillators: The Multicentre Italian ANGELS of AF Project

  2012cited by this paper
• How much atrial fibrillation is too much atrial fibrillation?

  2012cited by this paper
• Incidence and Prevalence of Atrial Fibrillation and Associated Mortality Among Medicare Beneficiaries: 1993–2007

  2012cited by this paper
• Clinical management of atrial fibrillation: need for a comprehensive patient-centered approach.

  2011cited by this paper
• Temporal relationship of atrial tachyarrhythmias, cerebrovascular events, and systemic emboli based on stored device data: a subgroup analysis of TRENDS.

  2011cited by this paper
• Detection of atrial high-rate events by continuous Home Monitoring: clinical significance in the heart failure–cardiac resynchronization therapy population

  2011cited by this paper
• Comprehensive risk reduction in patients with atrial fibrillation: Emerging diagnostic and therapeutic options

  2011cited by this paper
• Apixaban in patients with atrial fibrillation.

  2011cited by this paper
• Improving Stroke Risk Stratification Using the CHADS2 and CHA2DS2-VASc Risk Scores in Patients With Paroxysmal Atrial Fibrillation by Continuous Arrhythmia Burden Monitoring

  2011cited by this paper
• Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).

  2010cited by this paper
• Efficacy and Safety of Automatic Remote Monitoring for Implantable Cardioverter-Defibrillator Follow-Up: The Lumos-T Safely Reduces Routine Office Device Follow-Up (TRUST) Trial

  2010cited by this paper
• Incidence of Newly Detected Atrial Arrhythmias via Implantable Devices in Patients With a History of Thromboembolic Events

  2010cited by this paper
• Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).

  2010cited by this paper
• Stroke in paroxysmal atrial fibrillation: report from the Stockholm Cohort of Atrial Fibrillation.

  2010cited by this paper
• Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited.

  2009cited by this paper
• Presence and Duration of Atrial Fibrillation Detected by Continuous Monitoring: Crucial Implications for the Risk of Thromboembolic Events

  2009cited by this paper
• Home Monitoring in Patients with Implantable Cardiac Devices: Is There a Potential Reduction of Stroke Risk? Results from a Computer Model Tested Through Monte Carlo Simulations

  2009cited by this paper
• The Relationship Between Daily Atrial Tachyarrhythmia Burden From Implantable Device Diagnostics and Stroke Risk: The TRENDS Study

  2009cited by this paper
• Atrial fibrillation in stroke-free patients is associated with memory impairment and hippocampal atrophy.

  2008cited by this paper
• Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: an ACTIVE W Substudy.

  2007cited by this paper
• Telecardiology and Remote Monitoring of Implanted Electrical Devices: The Potential for Fresh Clinical Care Perspectives

  2007cited by this paper
• Secular Trends in Incidence of Atrial Fibrillation in Olmsted County, Minnesota, 1980 to 2000, and Implications on the Projections for Future Prevalence

  2006cited by this paper
• The epidemiological burden of atrial fibrillation: a challenge for clinicians and health care systems.

  2006cited by this paper
• Monitored atrial fibrillation duration predicts arterial embolic events in patients suffering from bradycardia and atrial fibrillation implanted with antitachycardia pacemakers.

  2005cited by this paper
• Asymptomatic atrial fibrillation: demographic features and prognostic information from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.

  2005cited by this paper
• Relationship between atrial tachyarrhythmias and symptoms.

  2005cited by this paper
• Asymptomatic atrial fibrillation.

  2005cited by this paper
• Long-term risk of recurrent atrial fibrillation as documented by an implantable monitoring device: implications for optimal patient care.

  2004cited by this paper
• Accuracy of Atrial Tachyarrhythmia Detection in Implantable Devices with Arrhythmia Therapies

  2004cited by this paper
• Atrial High Rate Episodes Detected by Pacemaker Diagnostics Predict Death and Stroke: Report of the Atrial Diagnostics Ancillary Study of the MOde Selection Trial (MOST)

  2003cited by this paper
• Clinical Utility of Intraatrial Pacemaker Stored Electrograms to Diagnose Atrial Fibrillation and Flutter

  2001cited by this paper
• Stroke with intermittent atrial fibrillation: incidence and predictors during aspirin therapy. Stroke Prevention in Atrial Fibrillation Investigators.

  2000cited by this paper
• Atherosclerotic disease of the aortic arch as a risk factor for recurrent ischemic stroke.

  1996cited by this paper
• Thrombus associated with mitral valve calcification. A possible mechanism for embolic stroke.

  1995cited by this paper
• Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study).

  1994cited by this paper
• Mitral annular calcification and the risk of stroke in an elderly cohort.

  1992cited by this paper

• Management von Vorhofflimmern 2026

  2026cites this paper
• Continuous Monitoring with Implantable Loop Recorders After Cryoballoon Ablation: Impact on Atrial Fibrillation Recurrence and Therapeutic Management in Era of Artificial Intelligence

  2025cites this paper
• Brazilian Atrial Fibrillation Guidelines - 2025.

  2025cites this paper
• Transthoracic Echocardiography Combined With the Clinical History Can Predict Left Atrial Thrombus in Patients With Nonvalvular Atrial Fibrillation

  2025cites this paper
• Preventive Measures and Treatment Options for Atrial Fibrillation.

  2025cites this paper
• Assessment of retinal and choroidal microcirculatory alterations following radiofrequency catheter ablation in atrial fibrillation patients using swept-source optical coherence tomography angiography

  2025cites this paper
• Anticoagulation in Patients with Atrial High-rate Episodes Detected by Cardiac Implantable Electronic Devices.

  2024cites this paper
• Epidemiology and clinical implications of atrial fibrillation among stroke patients in Ethiopia: a comprehensive systematic review and meta-analysis

  2024cites this paper
• Machine learning-based identification and validation of aging-related genes in cardiomyocytes from patients with atrial fibrillation.

  2024cites this paper
• Health behavior outcomes in stroke survivors prescribed wearables for atrial fibrillation detection stratified by age.

  2024cites this paper
• Robotic-Assisted Epicardial Hybrid Ablation and Left Appendage Closure in Persistent Atrial Fibrillation: First European Experience

  2024cites this paper
• Detection of subclinical atrial fibrillation with cardiac implanted electronic devices: What decision making on anticoagulation after the NOAH and ARTESiA trials?

  2024cites this paper
• Modeling Supraventricular Tachycardia Using Dynamic Computer-Generated Left Atrium

  2023cites this paper
• [Artificial intelligence in wearable electrocardiogram monitoring].

  2023cites this paper
• USE OF ANTICOAGULATION FOR THROMBOEMBOLIC PROPHYLAXIS IN PATIENTS WITH ATRIAL HIGH-RATE EPISODES ON DEVICE MONITORING: A NARRATIVE REVIEW.

  2023cites this paper
• A Review on Atrial Fibrillation Detection From Ambulatory ECG

  2023cites this paper
• Atrial fibrillation and stroke prevention: 25 years of research at EP Europace journal

  2023cites this paper
• Insertable cardiac monitoring results in higher rates of atrial fibrillation diagnosis and oral anticoagulation prescription after ischaemic stroke

  2023cites this paper
• Assessment of the atrial fibrillation burden in Holter electrocardiogram recordings using artificial intelligence.

  2023cites this paper
• Refinement of CHADS2 and CHA2DS2-VASc scores predict left atrial thrombus or spontaneous echo contrast in nonvalvular atrial fibrillation patients

  2022cites this paper
• Prevalence and Detection Methods for Atrial Fibrillation in Patients Hospitalized due to Ischemic Stroke and Its Impact on Clinical Patient Outcomes

  2022cites this paper
• Rhythm monitoring, success definition, recurrence, and anticoagulation after atrial fibrillation ablation: results from an EHRA survey

  2022influential citation
• Searching for atrial fibrillation: looking harder, looking longer, and in increasingly sophisticated ways. An EHRA position paper'.

  2022cites this paper
• Association of atrial fibrillation burden with in-hospital outcomes in patients with Takotsubo cardiomyopathy.

  2022cites this paper
• Atrial Fibrillation Detection With an Analog Smartwatch: Prospective Clinical Study and Algorithm Validation

  2022cites this paper
• Atrial fibrillation

  2022cites this paper
• Atrial high rate episodes as a marker of atrial cardiomyopathy: In the quest of the Holy Grail. Author's reply.

  2022cites this paper
• Detection and management of subclinical atrial fibrillation in implantable and wearable devices

  2021cites this paper
• Newer Diagnostic and Cost-Effective Ways to Identify Asymptomatic Atrial Fibrillation for the Prevention of Stroke

  2021cites this paper
• Clinical Factors Associated with Atrial Fibrillation Detection on Single-Time Point Screening Using a Hand-Held Single-Lead ECG Device

  2021cites this paper
• The challenge to improve knowledge on the interplay between subclinical atrial fibrillation, atrial cardiomyopathy, and atrial remodeling

  2021cites this paper
• Optimizing indices of atrial fibrillation susceptibility and burden to evaluate atrial fibrillation severity, risk and outcomes

  2021cites this paper
• Diagnosis of atrial fibrillation in heart failure patients with implantable cardioverter defibrillator or cardiac resynchronisation therapy

  2021cites this paper
• Knowledge, attitude, and practice regarding atrial fibrillation among primary care physicians: the potential role of postgraduate training.

  2021cites this paper
• Guía ESC 2020 sobre el diagnóstico y tratamiento de la fibrilación auricular, desarrollada en colaboración de la European Association of Cardio-Thoracic Surgery (EACTS)

  2021cites this paper
• Device-detected atrial high rate episodes and the risk of stroke/thrombo-embolism and atrial fibrillation incidence: a systematic review and meta-analysis.

  2021cites this paper
• Appropriateness of inpatient dosing of direct oral anticoagulants for atrial fibrillation

  2021cites this paper
• Impact of the Pattern of Atrial Fibrillation on Stroke Risk and Mortality

  2021cites this paper
• The safety of new oral anticoagulants for ischemic stroke and systemic embolism prevention in females with atrial fibrillation

  2021cites this paper
• Systematic errors in the choice of dose level of direct oral anticoagulants: urgency of an issue and approaches to its solution

  2021cites this paper
• What do we do about atrial high rate episodes?

  2020influential citation
• The difference of burden of ectopic beats in different types of atrial fibrillation and the effect of atrial fibrillation type on stroke risk in a prospective cohort of patients with atrial fibrillation (CODE-AF registry)

  2020cites this paper
• 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS).

  2020cites this paper
• Intrahospital organizational model of remote monitoring data sharing, for a global management of patients with cardiac implantable electronic devices: a document of the Italian Association of Arrhythmology and Cardiac Pacing.

  2020cites this paper
• Evaluating Physician Adherence to Antithrombotic Recommendations in Patients with Atrial Fibrillation: A Pathway to Better Medical Education

  2020cites this paper
• A Country-Based Comparison of Atrial Fibrillation Patient Preferences for Oral Anticoagulation: An Evaluation of Discrete Choice Experiments in five different Countries.

  2020cites this paper
• Telecardiology during the Covid-19 pandemic: past mistakes and future hopes.

  2020cites this paper
• Neuro-arrhythmology: a challenging field of action and research: a review from the Task Force of Neuro-arrhythmology of Italian Association of Arrhythmias and Cardiac Pacing.

  2019cites this paper
• Carotid Atherosclerosis in Patients with Atrial Fibrillation

  2019cites this paper
• Risk Assessment of Stroke in Patients with Atrial Fibrillation: Current Shortcomings and Future Directions

  2019cites this paper
• Pharmacological Cardioversion of Acute Atrial Fibrillation

  2019cites this paper
• Oral anticoagulation for subclinical atrial tachyarrhythmias detected by implantable cardiac devices: an international survey of the AF-SCREEN Group.

  2019cites this paper
• The Association Between Obstructive Sleep Apnea and Arrhythmias

  2019cites this paper
• Management of asymptomatic arrhythmias: a European Heart Rhythm Association (EHRA) consensus document, endorsed by the Heart Failure Association (HFA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), Cardiac Arrhythmia Society of Southern Africa (CASSA), and Latin America Hear

  2019cites this paper
• Atrial fibrillation

  2019cites this paper
• A novel biomarker for prediction of atrial fibrillation susceptibility in patients with celiac disease

  2018cites this paper
• Screening for atrial fibrillation: a European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad

  2018cites this paper
• Screening for atrial fibrillation: a European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLAECE).

  2018cites this paper
• Overweight and obesity in patients with atrial fibrillation: Sex differences in 1‐year outcomes in the EORP‐AF General Pilot Registry

  2018cites this paper
• Physician decision making in anticoagulating atrial fibrillation: a prospective survey of a physician notification system for atrial fibrillation detected on cardiac implantable electronic devices of patients at increased risk of stroke

  2018cites this paper
• Anticoagulation in the Patient with Cancer

  2018cites this paper
• Cardiovascular Ultrasound Combined With Non-invasive Screening for the Detection of Undiagnosed Cardiovascular Disease: A Literature Review

  2018cites this paper
• Comparison of cryoballoon and radiofrequency ablation techniques for atrial fibrillation: a meta-analysis

  2018cites this paper
• Physician decision making in anticoagulating atrial fibrillation: a prospective survey of a physician notification system for atrial fibrillation detected on cardiac implantable electronic devices of patients at increased risk of stroke.

  2018cites this paper
• Heart Failure and Stroke

  2018cites this paper
• Changes to oral anticoagulant therapy and risk of death over a 3-year follow-up of a contemporary cohort of European patients with atrial fibrillation final report of the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) pilot general registry.

  2018cites this paper
• Lessons from the current European Heart Rhythm Association consensus document on screening for atrial fibrillation

  2018cites this paper
• Screening for Atrial Fibrillation : a European Heart Rhythm Association ( EHRA ) consensus document endorsed by the Heart Rhythm Society ( HRS ) , Asia Pacific Heart Rhythm Society ( APHRS ) , and Societad Latinoamericana de Estimulation

  2018cites this paper
• Pacemaker-detected severe sleep apnoea predicts new-onset atrial fibrillation: Author's reply.

  2018cites this paper
• Atrial fibrillation in athletes: From epidemiology to treatment in the novel oral anticoagulants era.

  2018cites this paper
• l‐Carnitine and heart disease

  2018cites this paper
• Management of atrial high-rate episodes detected by cardiac implanted electronic devices

  2017cites this paper
• Controversies in postoperative atrial fibrillation after noncardiothoracic surgery: clinical and research implications

  2017cites this paper
• The increased risk of stroke/transient ischemic attack in women with a cardiac implantable electronic device is not associated with a higher atrial fibrillation burden

  2017cites this paper
• Detection of new atrial fibrillation in patients with cardiac implanted electronic devices and factors associated with transition to higher device-detected atrial fibrillation burden.

  2017cites this paper
• Optimum Risk Assessment for Stroke in Atrial Fibrillation: Should We Hold the Status Quo or Consider Magnitude Synergism and Left Atrial Appendage Anatomy?

  2017cites this paper
• Pharmacological and Non-pharmacological Treatments for Stroke Prevention in Patients with Atrial Fibrillation

  2017cites this paper
• Screening for atrial fibrillation: a European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulaci (cid:2) on Card (cid:2) ıaca y Electrofisiolog (cid:2) ıa (SOLAECE)

  2017cites this paper
• Atrial fibrillation prevention: an appraisal of current evidence

  2017cites this paper
• The complexity of atrial fibrillation newly diagnosed after ischemic stroke and transient ischemic attack: advances and uncertainties

  2017cites this paper
• Antithrombotic Therapy for Atrial Fibrillation: CHEST Guideline and Expert Panel Report

  2012cites this paper